Kim Sablich

Insider Reports History

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, Brisbane, CA
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kimbely Sablich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Sablich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jazz Pharmaceuticals plc EVP, GM of U.S. Ordinary Shares 28.5K $3.39M $119.13 Jun 5, 2023 Direct
Eiger BioPharmaceuticals, Inc. Director Stock Option (Right to Buy) 28K Mar 1, 2023 Direct

Insider Reports Filed by Kim Sablich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JAZZ Jazz Pharmaceuticals plc Jun 5, 2023 1 -$270K 4 Jun 7, 2023 EVP, GM of U.S.
JAZZ Jazz Pharmaceuticals plc Mar 8, 2023 2 -$421K 4 Mar 10, 2023 EVP, GM of U.S., Commercial Ma
JAZZ Jazz Pharmaceuticals plc Mar 3, 2023 2 -$230K 4 Mar 7, 2023 EVP, GM of U.S., Commercial Ma
EIGR Eiger BioPharmaceuticals, Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
JAZZ Jazz Pharmaceuticals plc Jun 6, 2022 7 -$842K 4 Jun 8, 2022 EVP & GM, North America
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director
JAZZ Jazz Pharmaceuticals plc Mar 3, 2022 2 -$115K 4 Mar 9, 2022 EVP & GM, North America
JAZZ Jazz Pharmaceuticals plc Nov 11, 2021 1 -$371K 4 Nov 15, 2021 EVP & GM, North America
JAZZ Jazz Pharmaceuticals plc Jun 5, 2021 1 -$256K 4 Jun 9, 2021 EVP & GM, North America